From: The economic burden of bronchiectasis – known and unknown: a systematic review
Reference | Time frame (cost year) | Annual cost per patient | |
---|---|---|---|
De la Rosa et al., 2016 [19] (Spain) | 2013 (2013) | Overall €4672 ± 6281 FACED 0–2: €2993 FACED 3–4: €4732 FACED 5–7: €9999 | |
Sanchez-Munoz et al., 2016 [18] (Spain) | 2004–2013 | Bronchiectasis 1° diagnosis 2004: €3961 2013: €3515 Time trend: p < 0.001 | Bronchiectasis 2° diagnosis 2004: €4327 2013: €4559 Time trend: p < 0.001 |
Weycker et al., 2005 [14] (USA) | 1999–2002 (2001) | Bronchiectasis: US$13,244 Control: US$7563 Incremental cost for bronchiectasis: US$5681 (95% CI US$4862–6593) | |
Joish et al., 2013 [12] (USA)a | January 2005 to December 2009 | Overall incremental cost of bronchiectasis: US$2319 (95% CI US$1872–2765) | Respiratory-related incremental cost of bronchiectasis: US$1607 (95% CI US$1406–1809) |
Joish et al., 2013 [34] (USA)a | July 2008 to July 2011 | Annual cost of bronchiectasis with exacerbation, US$37,030 Annual cost of bronchiectasis without exacerbation, US$26,284 Incremental cost, adjusting for baseline expenditure, US$8120 Incremental hospital costs: US$6147 | |
Joish et al., 2013 [35] (USA)a | July 2009 to July 2010 | Annual cost of bronchiectasis with exacerbation, US$35,718 Annual cost of bronchiectasis without exacerbation, US$26,868 Incremental cost, adjusting for baseline expenditure: US$7643 Incremental hospital costs: US$5772 | |
Blanchette et al., 2017 [9] (USA)b | 2007–2013 | Total healthcare cost per patient: For year before P. aeruginosa diagnosis: US$36,213 For year after P. aeruginosa diagnosis: US$67,764 Incremental cost: US$31,551 | |
Blanchette et al., 2016 [10] (USA)b | 2007–2013 | Adjusted total cost Incremental increase in patients with P. aeruginosa: US$56,499 Incremental hospital costs: US$41,972 |